Skip to main content
. Author manuscript; available in PMC: 2017 Aug 31.
Published in final edited form as: Ann Intern Med. 2014 Nov 4;161(9):650–658. doi: 10.7326/M14-0538

Appendix Table 1.

Fifteen Questions to Assess the Quality of Included Studies

Question Possible Answers (Score)
1. Was AF the primary exposure of interest? Yes (1) or no (0)
2. What was the reported temporal relationship between AF and SCI? Prospective (1), not prospective (0), or both (1)
3. Were the inclusion and exclusion criteria adequately described? Yes (1) or no (0)
4. Was the history of symptomatic stroke confirmed by detailed neurologic examination? Yes (1) or no (0)
5. Were autopsies, MRI, and CT done for the purpose of research (as opposed to clinical care)? Yes (1) or no (0)
6. What was the method of SCI diagnosis? MRI (3), CT (2), or autopsy (1)
7. Were the investigators blinded to the clinical history of patients during the ascertainment of SCIs? Yes (1) or no (0)
8. Were the SCIs ascertained by ≥1 investigator? Yes (1) or no (0)
9. Did the investigators attempt to distinguish SCIs from dilated perivascular spaces? Yes (1) or no (0)
10. Did the authors acknowledge whether they excluded leukoaraiosis from SCIs in their analysis? Yes (1) or no (0)
11. Did the investigators use diffusion-weighted imaging to distinguish acute SCIs from leukoaraiosis? Yes (1) or no (0)
12. Did the investigators distinguish chronic SCIs from leukoaraiosis by colocalizing the hyperintense lesions on T2-weighted images to nonterritorial FLAIR hyperdensity or prominent hypointense lesions (CSF intensity) on T1-weighted images? Yes (1 or no (0)
13. Was AF documented on ≥1 electrocardiography? Yes (1) or no (0)
14. Did the investigators assess or report carotid stenosis in study patients? Yes (1) or no (0)
15. Risk of confounding bias? Minimal (2) if studies controlled for ≥5 of following 6 potential confounders: age, sex, hypertension (or blood pressure measurements), DM, hyperlipidemia (or lipid profile measurements), and CAS (or carotid intima-media thickness) either by including these variables in the multivariate model or by ensuring that patients with and without AF were similar or matched on these variables; moderate (1) if studies did not control for ≥2 of these variables; or high (0) if studies did not control for any potential confounders.

AF = atrial fibrillation; CAS = carotid artery stenosis; CT = computed tomography; CSF = cerebrospinal fluid; DM = diabetes mellitus; FLAIR = fluid-attenuated inversion recovery; MRI = magnetic resonance imaging; SCI = silent cerebral infarction.